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Background 
Deep prosthetic joint infection (PJI) is a devastating complication of joint replacement surgery. It 
is difficult to treat, and patients often require multiple major revision surgeries to eradicate the 
infection. Treatment can have negative and long-term impact on patients’ quality of life. 
Understanding current service provision provides valuable information needed to design and 
evaluate support interventions for patients.  
 
Aim  
This survey aimed to identify usual care pathways and support in UK National Health Service 
(NHS) orthopaedic centres for patients receiving revision surgery for PJI after hip or knee 
replacement.  
 
Methods 
The 20 highest volume NHS orthopaedic centres treating prosthetic joint infection after hip or 
knee replacement were approached. Consultant orthopaedic surgeons specialising in treating 
PJI were invited to participate in a telephone or email survey about usual care provision and 
support for PJI. 
 
Findings 
Sixteen centres completed the survey. Findings showed a high degree of variation nationally in 
follow-up time-points after revision surgery. Multidisciplinary approaches to care focussed more 
on clinical care and physical rehabilitation than social and psychological care. Patient 
management and referral to support services also varied and barriers to referrals included lack 
of availability or access to services, lack of knowledge of services, shortage of staff, and 
complexities of referring outside of the hospital catchment area. 
 
Conclusion 
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Our findings suggest that future development of interventions should focus on more inclusive 
and patient-centred multidisciplinary approaches to care. Such interventions could more 
completely address psychological and social as well as physical aspects of patients’ recovery. 
 
 
Keywords (max 4): arthroplasty; orthopaedic infections; surgery; patient centred care 
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Introduction 
Approximately 187,000 people have hip or knee replacements in England, Wales, Northern 
Ireland and the Isle of Man each year (National Joint Registry, 2016a), (National Joint Registry, 
2016b). Perhaps the most devastating complication is deep prosthetic joint infection (PJI), which 
affects about 1% of patients (Blom et al, 2003), (Blom et al, 2004) although in some units 
estimates are as high as 5% (Briggs, 2015). Treatment costs to the National Health Service 
(NHS) for each patient with PJI are around £100,000 (Briggs, 2015). Infections occurring within 
two years of surgery are usually acquired during the operation, while infections occurring 
beyond two years are predominantly acquired through seeding from blood (Zimmerli et al, 
2004). Histories of diabetes, rheumatoid arthritis, depression, steroid use, and previous joint 
surgery are associated with an increased risk of developing PJI (Kunutsor et al, 2016a). 
Symptoms include inflammation, severe pain, loss of function, discharge from the surgical 
wound, fever and nausea; if left untreated, infections can result in disability and death (Zimmerli 
et al, 2004; Hunter & Dandy, 1977). PJI is difficult to treat, and patients often require multiple 
major surgeries and antibiotic therapy to eradicate the infection (Moore et al, 2015). PJI is 
associated with poor quality of life (Cahill et al, 2008), while re-infection occurs in around 8% of 
cases (Kunutsor et al, 2016; Kunutsor et al, 2015) and complications associated with surgery 
are common (Johnson et al, 2012; Jung et al, 2009). 
Patients’ experiences of PJI and treatment reveals that the infection itself and treatments 
impose heavy physical, social, and psychological burdens. Moore and colleagues’ study of 
patients from five high-volume NHS hospitals who underwent treatment for PJI following hip 
replacement showed that patients’ surgical histories are often complex, extend over many years 
and often involve multiple surgical revisions in an effort to eradicate infection (Moore et al, 
2015). Patients experience sudden and very negative changes in their quality of life, enduring 
severe pain and long periods of immobility, resulting in an inability to participate in daily 
personal, work and leisure activities leading to social isolation, and economic difficulties. These 
changes can persist into the long-term and some people have life-long chronic infections 
(Moore et al 2015; Andersson et al, 2010). Psychologically, patients experience anxieties that 
the infection might not heal or that it may return (approximately 8% experience re-infection 
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within two years) (Kunutsor et al, 2016; Kunutsor et al, 2015; Beswick et al, 2012), the 
implications of which are further surgery, long-term disability, and possible amputation. Some 
patients report depression and suicidal thoughts (Moore et al, 2015; Andersson et al, 2010). 
Cahill and colleagues note that more psychological and social support is needed for this group 
of patients, due to the negative impact on their social functioning and mental health (Cahill et al, 
2008) Patients rated their overall quality of life as poor with 12% of patients rating their current 
situation equivalent to, or worse than, death. Socially, the burden of care can impact negatively 
on members of the patient’s family, who often become carers, and while personal relationships 
can be a source of support they can also come under great strain (Moore et al, 2015; 
Andersson et al, 2010). Patients also report having to resign from employment, with consequent 
financial concerns (Moore et al, 2015; Andersson et al, 2010). Some older and less mobile 
patients report having to move residence, including unplanned downsizing or moving into 
nursing homes (Moore et al, 2015). 
Once discharged home, patients report numerous unmet complex needs that adversely affect 
their quality of life, including psychological support and physical rehabilitation. Patients describe 
feeling unprepared for the impact of revision treatment on themselves and their family, while 
those living alone are vulnerable to social isolation and loneliness. The physical implications of 
infection and treatment are also linked to distress, concern and uncertainty, with more 
rehabilitative support needed both during and after treatment and longer-term recovery (Moore 
et al, 2015). 
 
PJI is a complex condition that requires multidisciplinary medical and social management over 
the perioperative period and beyond. In patients with PJI this may range from months to years. 
Where patients have multiple unmet needs during and beyond the perioperative period it is 
reasonable to assume that a multidisciplinary approach to care may improve patient outcomes. 
Such approaches involve clinical and allied healthcare professionals (e.g. dietician, community 
nurses, orthogeriatricians) working together to formulate and deliver integrated patient-centred 
care to address the physical and psychosocial needs of the patient in an attempt to improve the 
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patient’s journey through clear communication, leadership, collaboration, and the streamlining of 
diagnostics and therapeutics (Denton & Conron, 2016; Borras et al, 2014)  
 
Currently there are no national guidelines or Department of Health advice on how best to 
manage patients with PJI. This may in part be due to a lack of consensus about the best way to 
treat PJI (Kunutsor et al 2016b; Kunutsor et al, 2015; Wongworawat, 2013). The current 
provision of NHS orthopaedic services is varied (Briggs, 2012) and it is uncertain what services 
are currently provided for PJI patients and how they are provided. Briggs (2012) suggests that 
there are large disparities in orthopaedic care and referrals in the NHS, and highlights the need 
for changes to improve pathways of care within these services, so as to improve patient 
experiences and outcomes. The report recommends that PJI is treated in specialist orthopaedic 
hospitals and that enhanced recovery pathways are developed – ensuring that patients receive 
the right treatment in the right place at the right time, with appropriate follow-up for patients 
(Briggs, 2012).  
 
Our previous work has documented the impact of PJI on patients and unmet needs during and 
after surgery (Moore et al, 2015). Combined with the large disparities in care (Briggs, 2015), 
management and care of patients with PJI should be a key research and clinical priority, starting 
with an exploration of current care pathways and referral processes. Findings from our previous 
research (Moore et al, 2015) and engagement with patients (Gooberman-Hill et al, 2013), 
indicates a pressing need to explore: what kind of support is available to patients with PJI; how 
they are managed during the perioperative period; whether they are referred to other services; 
and what clinical follow-up they receive.  
 
The aim of this study is to ascertain the scope of current service provision for patients treated 
for PJI after hip or knee replacement, and to identify potential barriers and facilitators to care 
provision for this population within NHS orthopaedic treatment centres that specialise in and 
deliver treatment for PJI. 
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Methods 
High-volume NHS orthopaedic centres, defined as those that perform more than 500 hip or 
knee operations per year were identified from the National Joint Registry, which collects 
information on joint replacement procedures performed within the NHS (Judge et al, 2006; 
National Joint Registry, 2016c). The twenty highest-volume orthopaedic centres treating PJI 
after hip or knee replacement in 2014 were identified. The orthopaedic department was 
contacted by telephone by a member of the research team and an appropriate consultant 
orthopaedic surgeon specialising in PJI was identified. This individual was then contacted by e-
mail inviting them to participate in the survey by telephone or e-mail. Data was collected for the 
survey between November 2015 and September 2016. 
The project was conducted as a service evaluation with agreement from the local NHS Trust 
and the NHS Research Ethics Committee (REC) that formal ethical approval was not required. 
 
Survey Questionnaire 
A structured survey questionnaire was developed in collaboration with an infection-specific 
Patient and Public Involvement group, which is part of the Patient Experience Partnership in 
Research (PEP-R) group (Gooberman-Hill et al, 2013). We based this process on procedures 
established in previous studies of service provision for post-operative total hip replacement and 
total knee replacement patients (Wylde et al, 2014; Artz et al 2013). The questionnaire was 
designed to ascertain service provision and care pathways for patients receiving surgical 
revision treatment for PJI after hip or knee replacement. The questionnaire covered topics 
including: follow-up times after revision surgery; communication pathways in the event of patient 
concerns or complications; routinely used outcome measures; type of support patients may be 
referred to; barriers to referrals; existence of specialist PJI clinics; and multidisciplinary 
approaches to care.  
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Data analysis 
Participants’ answers to the telephone questionnaire were recorded on a standardised proforma 
by the researcher. Telephone and e-mailed questionnaires were then saved to an encrypted 
database on a secure server. Questionnaire responses were anonymised through the allocation 
of an identification number for each centre. Responses were then exported into Microsoft Excel 
(Microsoft Office 2013) where they were reviewed and frequency statistics generated. Data 
summaries were then developed for each survey question and reviewed to ensure they 
reflected the raw data. Finally, a descriptive summary of the complete data set was developed. 
 
Results 
Respondents from 16 of the 20 highest volume orthopaedic centres completed the survey. In 
the year 2014 these 20 NHS orthopaedic centres accounted for 633 cases treated for PJI of the 
hip or knee. The 16 centres that responded account for 560 revision cases (88%) of the total of 
633 cases. The distribution of these orthopaedic centres included North West (n=1), West 
Midlands (n=2), East Midlands (n=2), South West (n=3), South East (n=5), East of England 
(n=1), Yorkshire and Humber (n=1), and South Wales (n=1). All respondents were consultant 
orthopaedic surgeons. Eleven respondents opted for the email questionnaire, and 5 
respondents opted to complete the questionnaire by telephone. Time to complete the 
questionnaire was approximately 10-15 minutes. 
 
Follow-up of patients who have received revision surgery for PJI. 
The time-points at which patients were routinely followed up after revision for infection varied 
across centres. Most centres saw patients at 6 weeks after revision surgery (n=10). Other 
centres followed up patients at 2 weeks (n=3), weekly (n=2) or within 4 weeks (n=1) if the 
infection was still present. Longer-term follow-up also varied with centres following up at 3, 6 
and 12 months. Nine centres stated that follow-up time-points were standardised (although 
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there was some variation dependent upon the patient's needs). Seven centres stated that 
follow-up time-points varied between consultant orthopaedic surgeons. One centre reported that 
they were trying to standardise their process. 
After being discharged following revision for infection, the period of time that patients were 
followed-up varied between centres and consultants. Centres follow up patients annually 
indefinitely (n=10), for up to 5 years (n=2) or 10 years (n=1), until the infection cleared (n=1), or 
up to 3 months if the infection has cleared (n=1). 
In the majority of centres (n=15) a consultant conducted the follow-up appointment. Commonly 
a registrar would be present (n=10), and in six centres a microbiologist was also present. In 
other centres an extended scope practitioner (n=5), a clinical nurse specialist (n=1) or nurse 
practitioner (n=1) would also attend. One centre stated that follow-up was conducted by the 
“bone infection team” with a specialist registrar present, and sometimes a consultant. It was 
established that only a small number of centres (n=4) held a dedicated PJI clinic. Twelve 
centres stated they had no infection clinic. 
Advice for patients on who to contact if they had any concerns varied greatly. The four units with 
a dedicated infection unit asked patients to call the infection clinic or Outpatient Parenteral 
Antimicrobial Therapy service. Seven centres asked patients to phone the consultant or the 
consultant's secretary. One centre asked patients to liaise with a community nurse, consultant's 
secretary, GP or Emergency Department. One centre had a dedicated orthopaedic community 
service that would see patients the same day. One centre gave out advice leaflets, though no 
further detail about contacts was given, and one centre gave out a card with contact numbers. 
Two centres discouraged patients from contacting their GP in the first instance.  
Making an appointment to be reviewed varied considerably between centres and most centres 
had no named person or clinician. A high proportion was via the secretary, GP or Emergency 
Department. One hospital gave patients a card with contact details but commented that patients 
sometimes found it very difficult to make contact with anyone at the hospital or to arrange an 
appointment to be reviewed. One hospital stated that it was difficult for patients to arrange a 
review if they lived out of the area. 
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Nine of 16 centres used the Oxford Hip Score or Oxford Knee Score and four of these centres 
used these outcome measures in conjunction with the EQ-5D-5L. One centre used the Harris 
Hip Score alongside the Oxford Hip Score, and one centre used the UCLA score alongside the 
Oxford score. Seven centres did not use any standardised outcome measures. 
The Oxford Hip Score and the Oxford Knee Score are short, self-administered questionnaires, 
which have been validated for use in total hip or total knee replacements. They consist of 12 
questions specifically designed and developed to assess pain and function after hip or knee 
replacement (Dawson, et al 1996; Dawson et al 1998). The Harris Hip Score is commonly used 
to assess disease-specific pain and function in THA patients. Patients are scored on a 0-100 
scale based on the degree of pain, function, and range of motion (Harris, 1969). The EuroQol 
EQ-5D-5L is a validated quality of life measure, consisting of a descriptive system (five 
dimensions; each dimension having five levels) and a visual analogue scale (patient’s self-rated 
health recorded on a 20-cm scale) (Brooks and Group, 1996). The University of California Los 
Angeles (UCLA) score is a 10-point activity-level rating, consisting of 10 descriptive activity 
levels ranging from wholly inactive (level1), to moderate activities such as unlimited housework 
and shopping (level 6), to regular participation in impact sports such as jogging or tennis (level 
10) (Zahiri et al, 1998). 
 
Management of patients with PJI and referral to other supportive services 
Five centres suggested those who had a two-stage revision generally needed more social 
support, physiotherapy and occupational therapy, or may need respite care or placement in a 
cottage hospital as they often needed inpatient care for longer than patients who had a one-
stage revision. However, one centre stated that there was little difference between levels of 
support for one-stage or two-stage revision, due to the type of spacer used that allowed for 
better functional mobility and weight-bearing. Another centre stated that they use this technique 
but did not comment on differences in the level of support required. Four centres stated that 
levels of support would vary depending on patient’s needs rather than being decided a priori on 
the basis of revision type. 
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Inpatient support and management services for patients being treated for PJI in all centres 
included physiotherapy and occupational therapy. Less than half of centres included social 
services (n=7), and three centres included counselling. One centre stated they provided 
"dedicated physio[therapy] and occupational therapy on a separate infection ward" while two 
centres reported that they provided "standard" or "usual" physiotherapy and occupational 
therapy. This suggests that there may be a lack of individualisation of physiotherapy and 
occupational therapy services for patients having revision surgery. Once patients were 
discharged home, most centres stated that they provided patients with physiotherapy (n=15), 
with some also stating occupational therapy (n=11) and social services (n=7). One centre 
provided a discharge liaison nurse to plan additional help, and one centre provided "hospital at 
home" to manage intravenous antibiotics. One centre commented that community services were 
"a waste of time" as they offer only limited treatment. 
During the interim period between a first and second stage revision, support and management 
options provided included physiotherapy and occupational therapy (n=10). At three centres, 
hospital at home or community services could help with intravenous antibiotics if needed. At 
three centres, support and management options would vary according to the patients’ needs. 
One centre reported that patients may go to intermediate care for rehabilitation. One centre had 
no planned support at this stage. Two centres did not answer this question. 
Across the centres, referrals to other services were made by consultants, trainees, GPs, ward 
staff, physiotherapists and extended scope practitioners. There was great variation between 
centres. One centre stated that it had implemented a special discharge team of nurses 
collaborating with ward doctors to work out what care and referrals were needed. One centre 
had a discharge liaison nurse. Two centres reported discussing referrals during multidisciplinary 
team meetings.  
 
Barriers to referrals 
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A number of barriers to referring patients to support services were identified across the centres. 
The most common barrier was a lack of service provision (no service or staff) and difficulties in 
accessing services (n=11). Five centres reported difficulties in referring patients outside their 
geographical catchment area and difficulties in financial repatriation. Delays in arranging 
services (n=4) and a lack of knowledge of what services were available (n=3) were also 
barriers. Other respondents noted delays in rehabilitation and that poor provision of social 
services presented barriers, while “consultant pride” could also be a barrier to referrals, 
suggesting that some consultants may find it unacceptable to refer patients on if they believe it 
will reflect negatively upon their own performance. One centre also expressed their frustration 
about dietetics services suggesting that more input was needed as patients were 
“malnourished” and that “wound healing is slow”. 
 
Multidisciplinary care approaches 
Multidisciplinary team meetings are a core component of the NHS’s drive towards integrated 
care for long-term conditions. Eleven centres stated that they had multidisciplinary care plans in 
place for patients. Five centres stated they had no multidisciplinary care plan for patients with 
PJI. Input into multidisciplinary care plans varied across centres and could include: “the infection 
team”; “microbiologists, radiologists and surgeons but not therapies”; consultant orthopaedic 
surgeon and microbiologist; consultant orthopaedic surgeon and nurse practitioners; and an 
orthogeriatrician. 
Fourteen out of 16 centres reported that they have multidisciplinary team meetings. Two centres 
stated they did not have multidisciplinary team meetings. Frequency of meetings varied from 
once a week to every 2 months. Two centres said the surgeon/consultant did not get involved in 
the meetings. 
 
Discussion 
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This survey of service provision for PJI after total hip or knee replacement found a high degree 
of variation nationally in follow-up processes, patient management and referral to support 
services, and multidisciplinary approaches to care. The majority of centres reported a standard 
follow-up time-point of six weeks, similar to the standard orthopaedic follow-up for treatment-
based decisions for postoperative recovery and bone healing, while some centres quoted earlier 
follow-up time-points such as 2 weeks, which equates to a clinical review to, for example, check 
wound healing or antibiotic treatment. In over half of the centres that responded, follow-up time-
points were standardised, while at other centres time-points varied between surgeons, although 
one centre suggested they were trying to standardise follow-up time-points. The benefit of 
standardising follow-up time-points is that patients will know in advance when they are being 
reviewed and will be able to plan visits to the hospital, which may be of psychological benefit as 
well as convenience to the patient. There are also financial implications as clinical reviews cost 
around £112.50 per patient (Department of Health, 2016). For longer-term follow-up, 10 of the 
16 centres reviewed patients annually indefinitely. Other centres limited follow-up to five or ten 
years, or until the infection had cleared. Following PJI, the risk of infection recurrence within 2 
years is around 8% (Triantafyllopoulos et al, 2016; Kunutsor et al, 2015) and revision for other 
causes is also high with the 10-year risk of re-revision for hips at 15% and 12-year risk for knees 
at 17% (National Joint Registry, 2016d). We suggest that as the risk of re-revision in this 
population is high, standardising follow-up time-points and indefinite follow-up would be 
judicious. 
 
For the majority of centres, follow-up appointments were conducted by a consultant orthopaedic 
surgeon and microbiologist and in seven centres an extended scope practitioner (e.g. 
physiotherapist), clinical nurse specialist, or nurse practitioner is also present. Given that our 
previous research and that of others shows that PJI has a long-term impact and a considerable 
number of unmet needs (Moore et al, 2015; Andersson et al, 2010), the inclusion of a 
multidisciplinary team during follow-up appointments may offer the opportunity for an earlier and 
more holistic assessment of the patient’s care needs, with signposting of local support services 
and other therapies. Although 14 centres reported that they had multidisciplinary team 
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meetings, the frequency of these varied greatly between centres. Eleven centres had 
multidisciplinary care plans, though input was generally from the orthopaedic/surgical team 
which often included a microbiologist, rather than from other clinical areas such as 
physiotherapy or social services. Apart from one centre, which involved an orthogeriatrician, our 
findings show there was little representation of other clinical and allied healthcare professionals 
during follow-up or providing input to multidisciplinary care plans. We suggest there is not of an 
inclusive multidisciplinary approach to the care of patients treated for PJI, and there may be 
missed opportunities for other clinicians and allied healthcare professionals to be involved 
perioperatively and in the longer-term. Just over half of the centres that responded did not use 
any standard outcome measures for PJI patients, which suggests there may be a lack of 
comparable clinical outcome data on changes in patients’ pain, function or psychological status, 
or quality of life in the years since contracting an infection. This important information may be 
useful to other members of the multidisciplinary teams involved in the rehabilitation of patients 
such as physiotherapists, occupational therapists, or counsellors as a way of recording 
improvements or deterioration over time. 
 
Referrals to other services mostly included physiotherapy and occupational therapy. Less than 
half of centres included social services and only three centres referred patients to counselling 
services. Research on the impact of PJI (Moore et al, 2015; Andersson et al, 2010; Cahill et al, 
2008; Barrack et al, 2000) shows that although there is a heavy physical burden on patients, the 
social and psychological impact of infection and treatment can also be devastating, and the 
results of this survey suggests these aspects are less supported by current care and 
management pathways.  
 
Surgeons in this survey identified a number of barriers to onward referrals including lack of 
service provision and access to some services, and problems referring patients from outside of 
the local NHS Trust catchment area. Given the recommendation for tertiary referral treatment 
for patients with PJI, the identified problem of referral for ongoing support following complex and 
costly surgical intervention is of particular concern. A lack of knowledge of available services 
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was also identified by three centres, which raises further questions about the added value of 
having a more multidisciplinary approach to the management of PJI, where other more 
generalised specialities such as orthogeriatricians may be better placed to offer a more holistic 
and person-centred approach (British Geriatrics society, 2007). It is not unreasonable to 
compare the multifaceted impact of PJI with that of other conditions such as cancer, as both 
share uncertain outcomes for radical surgical treatment, anxiety associated with the possible 
return of a malignant condition months or years later, and the heavy physical and psychological 
burden that the condition and its treatment impose on patients and their family (Simard et al, 
2013). In cancer care a person-centred, holistic and multidisciplinary approach is the standard 
(Gysels et al, 2004), and it may be that future collaboration between specialists from both areas 
may help to improve services for PJI. 
 
 
Strengths and weaknesses 
Although not all of the centres replied to our survey, the 16 we surveyed accounted for 88% of 
the revisions for PJI across the 20 centres. Views on support and management of PJI were 
supplied by consultant orthopaedic surgeons and although they specialise in the surgical 
treatment of PJI, it may be that other practitioners, such as nurses or extended scope 
practitioner physiotherapists, would have different perspectives on patient care and 
management, particularly in the post-operative stages. Although this may be a limitation of the 
survey, participants were given scope to explain their answers. We aim to conduct further 
research using qualitative methods, which will help us to gain further understanding of service 
provision for PJI. Another limitation of this survey method is that consultant surgeons’ 
perceptions of service provision in their unit, may not reflect actual practice, and other surgeons 
and clinicians in the same unit may have a different experience of what occurs in practice. We 
aim to conduct further research into care pathways for PJI using qualitative methods, which will 
help us to gain further understanding of service provision for PJI. 
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Caution should be used when interpreting these results as we did not set out to suggest 
whether differences in service provision were associated with differences in clinical outcomes. 
What we have established is that there is a large variation between a group of high-volume 
orthopaedic treatment centres in terms of follow-up, referral and multidisciplinary approaches to 
care. 
 
Conclusion 
Although the findings of our evaluation are limited to 16 high-volume NHS centres, they can be 
used in the development of research and the implementation of research findings into clinical 
practice. Our findings suggest that interventions should focus on more inclusive and patient-
centred multidisciplinary approaches to care, which fully address the psychological and social 
as well as physical aspects of patients’ recovery, and their return to full potential. The next steps 
will be to develop, implement and evaluate enhanced care pathways for people with PJI after 
hip and knee replacement. 
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